Suchergebnisse - "Ogama, Yoichiro"

PubPharm (20)

1

Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics

enthalten in: Clinical pharmacology in drug development | 2023

von Ogama, Y. | Kumagai, Y. | Komatsu, N. | +10

2

Pharmacokinetics and safety of CT-P17 (40 mg/0.4 ml) versus reference adalimumab : randomized study in healthy Japanese adults

enthalten in: Immunotherapy | 2023

von Haranaka, M. | Tanaka, T. | Kim, S. | +6

3

Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics

enthalten in: Clinical Pharmacology in Drug Development | 2023

von Ogama, Y. | Kumagai, Y. | Komatsu, N. | +10

4

Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI-589 in Healthy Participants

enthalten in: Clinical pharmacology in drug development | 2022

von Noda, N. | Hamatani, T. | Shibue, Y. | +5

5

Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI‐589 in Healthy Participants

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Noda, N. | Hamatani, T. | Shibue, Y. | +5

6

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults

enthalten in: Nature communications | 2021

von Haranaka, M. | Baber, J. | Ogama, Y. | +10

7

Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers

enthalten in: Pharmacology research & perspectives | 2021

von Noda, N. | Takagaki, T. | Yodo, Y. | +5

8

Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers

enthalten in: Pharmacology Research & Perspectives | 2021

von Noda, N. | Takagaki, T. | Yodo, Y. | +5

9

Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects

enthalten in: Drug research | 2017

von Kasahara-Ito, N. | Fukase, H. | Ogama, Y. | +9

10

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers

enthalten in: International journal of hematology | 2013

von Ogama, Y. | Mineyama, T. | Yamamoto, A. | +4